Louisiana State Employees Retirement System Buys 200 Shares of Doximity, Inc. $DOCS

Louisiana State Employees Retirement System raised its stake in Doximity, Inc. (NASDAQ:DOCSFree Report) by 0.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,600 shares of the company’s stock after acquiring an additional 200 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Doximity were worth $2,306,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of DOCS. Wealth Enhancement Advisory Services LLC bought a new position in Doximity in the 4th quarter valued at about $244,000. UMB Bank n.a. raised its holdings in Doximity by 128.0% in the 1st quarter. UMB Bank n.a. now owns 1,311 shares of the company’s stock valued at $76,000 after acquiring an additional 736 shares during the period. Harbor Capital Advisors Inc. bought a new position in Doximity in the 1st quarter valued at about $1,277,000. Yousif Capital Management LLC raised its holdings in Doximity by 2.1% in the 1st quarter. Yousif Capital Management LLC now owns 47,357 shares of the company’s stock valued at $2,748,000 after acquiring an additional 954 shares during the period. Finally, GAMMA Investing LLC raised its holdings in Doximity by 62.3% in the 1st quarter. GAMMA Investing LLC now owns 2,816 shares of the company’s stock valued at $163,000 after acquiring an additional 1,081 shares during the period. 87.19% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Canaccord Genuity Group increased their price target on shares of Doximity from $59.00 to $67.00 and gave the company a “hold” rating in a report on Thursday, September 18th. Zacks Research cut shares of Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Bank of America raised their target price on shares of Doximity from $55.00 to $62.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. JPMorgan Chase & Co. reaffirmed an “underweight” rating and set a $62.00 target price on shares of Doximity in a report on Friday. Finally, Robert W. Baird raised their target price on shares of Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Doximity has a consensus rating of “Hold” and an average target price of $69.37.

Read Our Latest Analysis on DOCS

Doximity Trading Down 9.5%

NASDAQ DOCS opened at $65.70 on Friday. The firm has a market capitalization of $12.31 billion, a price-to-earnings ratio of 65.70, a P/E/G ratio of 4.10 and a beta of 1.38. The firm’s 50 day simple moving average is $68.46 and its 200 day simple moving average is $60.96. Doximity, Inc. has a 1 year low of $40.87 and a 1 year high of $85.21.

Doximity (NASDAQ:DOCSGet Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. Doximity’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter last year, the business posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total value of $1,500,000.00. Following the sale, the director owned 3,221 shares in the company, valued at $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Regina M. Benjamin sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $70.50, for a total transaction of $352,500.00. Following the completion of the sale, the director owned 19,839 shares in the company, valued at $1,398,649.50. This represents a 20.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,000 shares of company stock worth $2,281,680 over the last quarter. Corporate insiders own 31.30% of the company’s stock.

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.